Physician profile
Mary E Schmitz
NPI 1639764145
$2,585.68
in general payments reported to CMS, 2019-2025
27 companies · $1,331 in 2025
The $1,331 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $362 · 2023: $446 · 2024: $446 · 2025: $1,331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,155 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,155.38 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $471.68 | 2022-2025 | Provenge |
| Janssen Biotech, INC. | $421.78 | 2025 | Erleada, Rybrevant, Carvykti |
| Merck Sharp & Dohme LLC | $183.57 | 2022-2024 | Keytruda |
| Endo USA, INC. | $175.80 | 2024-2025 | Xiaflex, Aveed |
| Sumitomo Pharma America, INC. | $120.84 | 2023-2025 | Orgovyx, Gemtesa |
| Endo Pharmaceuticals INC. | $119.53 | 2022-2024 | Xiaflex, Aveed |
| Tolmar, INC. | $106.62 | 2023-2025 | Eligard, Jatenzo |
| Progenics Pharmaceuticals, INC. | $102.76 | 2023-2025 | Pylarify |
| Axonics, INC. | $99.79 | 2022-2023 | Bulkamid |
| Ferring Pharmaceuticals INC. | $97.72 | 2024-2025 | Adstiladrin |
| 180 Medical, INC. | $87.00 | 2023-2025 | Gentlecath, Gentlecath Glide |
| Coloplast Corp | $85.46 | 2023-2025 | Titan |
| Bayer Healthcare Pharmaceuticals INC. | $69.96 | 2024-2025 | |
| Laborie Medical Technologies Corp. | $52.91 | 2023-2024 | Eclipse |
| Calyxo, INC. | $51.96 | 2025 | Cvac Aspiration System |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $44.70 | 2025 | |
| Teleflex LLC | $37.78 | 2024 | Urolift |
| Urogen Pharma, INC. | $37.55 | 2023-2024 | Jelmyto |
| Palette Life Sciences, INC. | $34.44 | 2022 | |
| Novartis Pharmaceuticals Corporation | $32.63 | 2025 | |
| Blue Earth Diagnostics | $32.26 | 2025 | Posluma |
| Boston Scientific Corporation | $29.35 | 2023 | Spaceoar Vue System - 10ml |
| Medtronic, INC. | $25.00 | 2023 | Interstim |
| Olympus America INC. | $20.92 | 2023 | Itind System |
| Immunitybio, INC. | $15.75 | 2024 | |
| Hollister Incorporated | $14.52 | 2022 | |
| Urovant Sciences INC | $13.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Schmitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.